Notices. Notice of application
172 words·~1 min read·
/register/2020/03/19/2020-05750A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-14-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-602] Bulk Manufacturer of Controlled Substances Application: Navinta LLC ACTION: Notice of application. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 18, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention:
DEA **Federal Register** Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on September 23, 2019, Navinta LLC, 1499 Lower Ferry Road, Ewing, New Jersey 08618-1414 registered as a bulk manufacturer of the following basic class(es), of controlled substances: Controlled substance Drug code Schedule 4-Anilino-N-phenethyl-4-piperidine
(ANPP)8333 II Levomethorphan 9210 II Levorphanol 9220 II Remifentanil 9739 II Fentanyl 9801 II The company plans to bulk manufacture API quantities of the listed controlled substances for validation purposes and FDA approval. Dated: March 5, 2020. William T. McDermott, Assistant Administrator. [FR Doc. 2020-05750 Filed 3-18-20; 8:45 am]
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Notices
Notice of application
Cites 1Cited by 0 across 0 sources